Boston, NY10 Active Studies

Type 1 Diabetes Clinical Trials in Boston, NY

Find 10 actively recruiting type 1 diabetes clinical trials in Boston, NY. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
7,194
Enrolling

Recruiting Type 1 Diabetes Studies in Boston

NCT06141434Recruiting

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

This research study is called 'PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life: The PROMISE Study'. The purpose of this study is to find out more about how exposures d...

Boston, NY6,000 participantsUniversity of Colorado, Denver
View Study Details
NCT07676565Recruiting

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will e...

Boston, NY300 participantsIndiana University
View Study Details
NCT07011147Recruiting

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) ...

Boston, NY240 participantsUniversity of Colorado, Denver
View Study Details
NCT07187531Recruiting

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Typ...

Boston, NY159 participantsSAb Biotherapeutics, Inc.
View Study Details
NCT06217302Recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Wheth...

Boston, NY150 participantsAlessandro Doria
View Study Details
NCT02734277Recruiting

Type 1 Diabetes Extension Study

This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodula...

Boston, NY111 participantsNational Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
NCT07224321Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 year...

Boston, NY100 participantsMannkind Corporation
View Study Details
NCT07142252Recruiting

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (...

Boston, NY66 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
View Study Details
NCT04786262Recruiting

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia....

Boston, NY52 participantsVertex Pharmaceuticals Incorporated
View Study Details
NCT06919354Recruiting

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell the...

Boston, NY16 participantsGentiBio, Inc
View Study Details

About Type 1 Diabetes Clinical Trials in Boston

Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. It typically develops in childhood or young adulthood and requires lifelong insulin therapy. Research is exploring artificial pancreas systems, immunotherapy, and beta cell replacement.

There are currently 10 type 1 diabetes clinical trials recruiting participants in Boston, NY. These studies are seeking a combined 7,194 participants. Research is being sponsored by University of Colorado, Denver, Indiana University, SAb Biotherapeutics, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Type 1 Diabetes Clinical Trials in Boston — FAQ

Are there type 1 diabetes clinical trials in Boston?

Yes, there are 10 type 1 diabetes clinical trials currently recruiting in Boston, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What type 1 diabetes treatments are being tested?

The 10 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for type 1 diabetes.

Data updated July 13, 2026 from ClinicalTrials.gov